Public Policy
HIMSS23
Lawrence Voyten, HIMSS board member and national advocacy chair, details how HIMSS chapter leaders can proactively support health equity and interoperability with their local governments.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.
The feature monitors heart rhythms suggestive of atrial fibrillation through the Galaxy Watch.
According to an audit by the Office of the Inspector General, Medicare improperly paid for $580 million of psychotherapy care, including $348 million of telehealth services, during the first year of the COVID-19 public health emergency.
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.
HIMSS23
Drew Ivan, Rhapsody's chief strategy officer, discusses how health systems can leverage digital solutions to manage data more efficiently while building regulatory compliance and flexibility into their IT infrastructure.
At HIMSS23, Jodi Daniel, managing director of Crowell Health Solutions, discussed the evolving policy landscape for telehealth, remote patient monitoring and other digital health technologies as the public health emergency comes to a close.
Homeward's Amar Kendale, former chief product officer at Livongo and Teladoc, discusses how the industry must combine technology and new care models to improve access and make value-based payment successful.
A federal jury found three former executives guilty of defrauding investors and clients, largely pharma companies.